Supported with intensive nursing follow post hospitalization
OtherIntensive nursing follow post - hospitalization
NCT Number: NCT02721316
To evaluate the impact of a specific nursing management (personalized and close, through consultation at the hospital, at home or by phone) monitoring in post-hospitalization, the suicide attempt of recurrence and suicidal crisis, in the year following a suicide attempt in patients suffering from a mood disorder (unipolar or bipolar) or reactive depression.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Main objective: To evaluate the impact of a specific nursing management (personalized and close, through consultation at the hospital, at home or by phone) monitoring in post-hospitalization, the suicide attempt of recurrence and suicidal crisis, in the year following a suicide attempt in patients suffering from a mood disorder (unipolar or bipolar) or reactive depression.
Secondary objectives:
Studying during the year following the suicide attempt index, the impact of this device on:
Studying patient compliance with intensive nursing monitoring program.
To study the role of the nurse to determine the factors that promote the construction of a therapeutic alliance.
Establish a mapping of needs and resources suicidal patient for nursing care in post-emergency.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intensive nursing follow post - hospitalization
Time frame: 12 months from EPAC (Emergency Psychiatry and Acute Care) discharge
Composite endpoint including any of the following events:
Time frame: 12 months from EPAC discharge
Occurrence of at least one suicide attempt, defined as medically documented or self-reported attempt or death by suicide
Time frame: 12 months from EPAC discharge
Occurrence of at least one emergency hospitalization for suicidal crisis, defined as persistent and high-intensity suicidal ideations
Time frame: 3 months, 6 months and 12 months after EPAC discharge
Increase ≥2 points on the C-SSRS severity score compared with EPAC discharge
Time frame: At inclusion, at EPAC discharge, and at 3 months, 6 months and12 months after EPAC discharge
Frequency of suicidal ideation measured with the C-SSRS (Columbia-Suicide Severity Rating Scale).
Time frame: At inclusion, at EPAC discharge, and at 3 months, 6 months and 12 months after EPAC discharge
Intensity of suicidal ideation measured with the C-SSRS (Columbia-Suicide Severity Rating Scale).
Time frame: At inclusion, at EPAC discharge, and at 3 months, 6 months and 12 months after EPAC discharge
Psychological pain measured with Visual Analog Scale (VAS)
Time frame: At 3 months, 6 months and12 months after EPAC discharge
Time frame: At 3 months, 6 months and12 months after EPAC discharge
Time frame: At 3 months, 6 months and12 months after EPAC discharge
Time frame: At 12 months after EPAC discharge
Time frame: At inclusion, at 3 months, 6 months and12 months after EPAC discharge
Time frame: 12 months after EPAC discharge
University Hospital, Montpellier
Other
Randomized Study of Ambulatory Monitoring Nurse Under the Prevention of Recurrent Suicidal
Acronym: SIPRéS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00001177
Menstruation Disturbances, Mental Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT00001231
Behavior, Behavioral Symptoms
Bethesda, Maryland, United States
View Trial DetailsNCT04339790
Anxiety Disorder, Anxiety Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT00105378
Behavior, Behavioral Symptoms
Nijmegen, Gelderland, Netherlands
View Trial Details